General Information of Drug Off-Target (DOT) (ID: OTX0PCR3)

DOT Name T-cell immunomodulatory protein (ITFG1)
Synonyms Protein TIP; Integrin-alpha FG-GAP repeat-containing protein 1; Linkin
Gene Name ITFG1
Related Disease
Acute graft versus host disease ( )
Acute otitis media ( )
Adult teratoma ( )
Advanced cancer ( )
Breast cancer ( )
Breast carcinoma ( )
Breast neoplasm ( )
Cystic fibrosis ( )
Invasive breast carcinoma ( )
Joubert syndrome ( )
Neoplasm ( )
Otitis media ( )
Teratoma ( )
Graft-versus-host disease ( )
UniProt ID
TIP_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF13517
Sequence
MAAAGRLPSSWALFSPLLAGLALLGVGPVPARALHNVTAELFGAEAWGTLAAFGDLNSDK
QTDLFVLRERNDLIVFLADQNAPYFKPKVKVSFKNHSALITSVVPGDYDGDSQMDVLLTY
LPKNYAKSELGAVIFWGQNQTLDPNNMTILNRTFQDEPLIMDFNGDLIPDIFGITNESNQ
PQILLGGNLSWHPALTTTSKMRIPHSHAFIDLTEDFTADLFLTTLNATTSTFQFEIWENL
DGNFSVSTILEKPQNMMVVGQSAFADFDGDGHMDHLLPGCEDKNCQKSTIYLVRSGMKQW
VPVLQDFSNKGTLWGFVPFVDEQQPTEIPIPITLHIGDYNMDGYPDALVILKNTSGSNQQ
AFLLENVPCNNASCEEARRMFKVYWELTDLNQIKDAMVATFFDIYEDGILDIVVLSKGYT
KNDFAIHTLKNNFEADAYFVKVIVLSGLCSNDCPRKITPFGVNQPGPYIMYTTVDANGYL
KNGSAGQLSQSAHLALQLPYNVLGLGRSANFLDHLYVGIPRPSGEKSIRKQEWTAIIPNS
QLIVIPYPHNVPRSWSAKLYLTPSNIVLLTAIALIGVCVFILAIIGILHWQEKKADDREK
RQEAHRFHFDAM
Function Modulator of T-cell function. Has a protective effect in graft versus host disease model.
Tissue Specificity Ubiquitously expressed.

Molecular Interaction Atlas (MIA) of This DOT

14 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Acute graft versus host disease DIS8KLVM Strong Biomarker [1]
Acute otitis media DISL8D8G Strong Biomarker [2]
Adult teratoma DISBY81U Strong Genetic Variation [3]
Advanced cancer DISAT1Z9 Strong Biomarker [4]
Breast cancer DIS7DPX1 Strong Biomarker [5]
Breast carcinoma DIS2UE88 Strong Biomarker [5]
Breast neoplasm DISNGJLM Strong Altered Expression [6]
Cystic fibrosis DIS2OK1Q Strong Biomarker [7]
Invasive breast carcinoma DISANYTW Strong Biomarker [5]
Joubert syndrome DIS7P5CO Strong Biomarker [8]
Neoplasm DISZKGEW Strong Biomarker [4]
Otitis media DISGZDUO Strong Biomarker [2]
Teratoma DIS6ICY4 Strong Genetic Variation [3]
Graft-versus-host disease DIS0QADF Limited Biomarker [9]
------------------------------------------------------------------------------------
⏷ Show the Full List of 14 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
9 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of T-cell immunomodulatory protein (ITFG1). [10]
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of T-cell immunomodulatory protein (ITFG1). [11]
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of T-cell immunomodulatory protein (ITFG1). [12]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of T-cell immunomodulatory protein (ITFG1). [13]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of T-cell immunomodulatory protein (ITFG1). [14]
Hydrogen peroxide DM1NG5W Approved Hydrogen peroxide decreases the expression of T-cell immunomodulatory protein (ITFG1). [15]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 decreases the expression of T-cell immunomodulatory protein (ITFG1). [18]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of T-cell immunomodulatory protein (ITFG1). [19]
Formaldehyde DM7Q6M0 Investigative Formaldehyde increases the expression of T-cell immunomodulatory protein (ITFG1). [20]
------------------------------------------------------------------------------------
⏷ Show the Full List of 9 Drug(s)
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Fulvestrant DM0YZC6 Approved Fulvestrant decreases the methylation of T-cell immunomodulatory protein (ITFG1). [16]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene affects the methylation of T-cell immunomodulatory protein (ITFG1). [17]
------------------------------------------------------------------------------------

References

1 Characterization of Plasmodium berghei Homologues of T-cell Immunomodulatory Protein as a New Potential Candidate for Protecting against Experimental Cerebral Malaria.Korean J Parasitol. 2019 Apr;57(2):101-115. doi: 10.3347/kjp.2019.57.2.101. Epub 2019 Apr 30.
2 The "TIP algorithm" for the accurate diagnosis of pediatric otitis media.Int J Pediatr Otorhinolaryngol. 2019 Sep;124:185-189. doi: 10.1016/j.ijporl.2019.05.028. Epub 2019 May 27.
3 Surgical Management of Patients with Advanced Germ Cell Tumors Following Salvage Chemotherapy: Memorial Sloan Kettering Cancer Center (MSKCC) Experience.Urology. 2019 Feb;124:174-178. doi: 10.1016/j.urology.2018.09.024. Epub 2018 Oct 6.
4 TIP: A Web Server for Resolving Tumor Immunophenotype Profiling.Cancer Res. 2018 Dec 1;78(23):6575-6580. doi: 10.1158/0008-5472.CAN-18-0689. Epub 2018 Aug 28.
5 RUVBL1-ITFG1 interaction is required for collective invasion in breast cancer.Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1788-1800. doi: 10.1016/j.bbagen.2017.03.016. Epub 2017 Mar 21.
6 #NAME?
7 Economic Evaluation of Tobramycin Inhalation Powder for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis.Clin Drug Investig. 2017 Aug;37(8):795-805. doi: 10.1007/s40261-017-0537-9.
8 A CEP104-CSPP1 Complex Is Required for Formation of Primary Cilia Competent in Hedgehog Signaling.Cell Rep. 2019 Aug 13;28(7):1907-1922.e6. doi: 10.1016/j.celrep.2019.07.025.
9 TIP, a T-cell factor identified using high-throughput screening increases survival in a graft-versus-host disease model.Nat Biotechnol. 2003 Mar;21(3):302-7. doi: 10.1038/nbt797. Epub 2003 Feb 24.
10 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
11 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
12 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
13 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
14 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
15 Oxidative stress modulates theophylline effects on steroid responsiveness. Biochem Biophys Res Commun. 2008 Dec 19;377(3):797-802.
16 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
17 Effect of aflatoxin B(1), benzo[a]pyrene, and methapyrilene on transcriptomic and epigenetic alterations in human liver HepaRG cells. Food Chem Toxicol. 2018 Nov;121:214-223. doi: 10.1016/j.fct.2018.08.034. Epub 2018 Aug 26.
18 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
19 Isobaric tags for relative and absolute quantitation-based proteomics analysis of the effect of ginger oil on bisphenol A-induced breast cancer cell proliferation. Oncol Lett. 2021 Feb;21(2):101. doi: 10.3892/ol.2020.12362. Epub 2020 Dec 8.
20 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.